Predicting Harms and Benefits in Translational Trials: Ethics, Evidence, and Uncertainty
Table 2
Outcomes in randomized trials of neuroregenerative and/or cell-transplantation strategies for Parkinson's disease.
doi: https://doi.org/10.1371/journal.pmed.1001010.t002